Question 1

Does it hurt?

Accepted Answer

Not at all. You lie comfortably on a couch, fully clothed, and nothing touches you. No needles, no surgery, no anaesthesia. Most people feel nothing during a session and quite a few fall asleep.

Question 2

How long does each session take?

Accepted Answer

About an hour, daily across your course. The timetable is built around the rest of your treatment plan so your main treatment always comes first — we work the sequencing out with you at consultation.

Question 3

Is this radiation, like radiotherapy or a CT scan?

Accepted Answer

No. The Cytotron® works at the gentle, non-ionising end of the electromagnetic spectrum, below mobile phone frequencies. There is no radioactivity and none of the dose limits that apply to radiotherapy.

Question 4

Are there side effects?

Accepted Answer

The therapy is generally very well tolerated. Where people notice something it is usually mild and passes quickly: tiredness in the first few days, occasionally a feeling of warmth in the treated area, sometimes a few nights of altered sleep. Please tell us about anything at all, however small.

Question 5

Can I drive myself? Can I keep working?

Accepted Answer

Yes to both. There is no sedation and no recovery period, so you can drive yourself home and carry on with your day. Most of our patients keep working, depending on how their main treatment is affecting them.

Question 6

How many sessions will I need?

Accepted Answer

Your course length is set at consultation from your own scans and situation. We agree it in writing before you start and it stays fixed, so you always know where you stand.

Question 7

What has the FDA said about the Cytotron®?

Accepted Answer

In October 2019 the US FDA granted the Cytotron® Breakthrough Device Designation for solid tumours of the breast, liver and pancreas. That is a priority review pathway for devices addressing serious conditions.

Question 8

Where else is it approved?

Accepted Answer

CE marked across the European Union since 2012, and approved for clinical use by the SFDA in Saudi Arabia and COFEPRIS in Mexico. It is in clinical use in around nine countries, with roughly thirty installations worldwide.

Question 9

What does the research show?

Accepted Answer

The most substantial publication is a peer-reviewed 2016 study of patients with advanced solid tumours treated for an hour a day over 28 days. It reported improved quality-of-life and daily-function scores, stable disease on imaging in most patients reviewed at one month, survival beyond what a standard prognostic model predicted, and no serious adverse events. It was a single-arm pilot study, so larger randomised trials are the next step.

Question 10

Can you tell me what my chances are?

Accepted Answer

Every cancer behaves differently, so no clinic can honestly give you a number. What we can do is look carefully at your specific situation and tell you what is reasonable to hope for — at consultation, before you commit to anything.

Question 11

Which cancers do you treat?

Accepted Answer

Solid tumours. Breast, liver and pancreatic cancers carry the device's FDA Breakthrough Device Designation. We also see patients with brain tumours, prostate, colorectal, lung and other solid cancers.

Question 12

How does this fit with the treatment I'm already having?

Accepted Answer

That is exactly the conversation to have with us. Cytotron® therapy is never offered instead of your oncology care — it is planned into your wider treatment, and the sequencing is worked out case by case from your reports, where you are in your current treatment and what your oncologist advises. With your permission we speak to them directly. Send us your reports and we will explain plainly how it would fit for you.

Question 13

Is it suitable if my cancer is advanced?

Accepted Answer

Often, yes, and much of the published work involves advanced disease. But suitability depends on your scans, blood counts and general condition. Send your reports and we will tell you honestly.

Question 14

What if you don't think it will help me?

Accepted Answer

We will say so plainly and explain why. We would rather lose a booking than take money from a family for something unlikely to help them.

Question 15

What does it cost?

Accepted Answer

Your course is quoted as a single fixed figure in writing after your consultation, covering sessions, reviews and coordination with your oncologist. It does not change mid-course. Ask us for the current schedule.

Question 16

Do I need to stay in Gurugram, India?

Accepted Answer

Sessions are daily, so most out-of-town patients stay nearby for the course. We can suggest accommodation at a range of budgets and help you plan travel.

Question 17

I'm travelling from outside India — can you help?

Accepted Answer

Yes. We support international patients with the paperwork for a medical visa, airport pickup, accommodation and a single point of contact throughout.

Question 18

How do I start?

Accepted Answer

Send your recent reports for a free records review. A doctor reads them personally and replies within one working day — no charge, no obligation.

Your questions answered

About the treatment

Recognition and research

Whether it suits you

Practical matters